Ammar Sabilarrohman

Strengthening Lebanon’s Health Resilience: EIB Global and WHO Sign €10 Million Strategic Partnership

• Global Breast Cancer Awareness

Strengthening Lebanon’s Health Resilience: EIB Global and WHO Sign €10 Million Strategic Partnership

Ammar Sabilarrohman September 14, 2026

LUXEMBOURG – In a significant move to fortify Lebanon’s crumbling public health infrastructure, the World Health Organization...

Read More Read more about Strengthening Lebanon’s Health Resilience: EIB Global and WHO Sign €10 Million Strategic Partnership

Philanthropy as a Catalyst: Strengthening Global Health Equity in an Era of Turbulence

• Breast Cancer Prevention and Lifestyle

Philanthropy as a Catalyst: Strengthening Global Health Equity in an Era of Turbulence

Ammar Sabilarrohman September 14, 2026

In the contemporary landscape of global health, the intersection of private capital and public policy has become...

Read More Read more about Philanthropy as a Catalyst: Strengthening Global Health Equity in an Era of Turbulence

BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

• Medical Research and Clinical Trials

BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

Ammar Sabilarrohman September 13, 2026

San Rafael, CA – October 26, 2023 – BioMarin Pharmaceutical Inc. has announced a significant milestone in...

Read More Read more about BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

• Genomics and Precision Medicine

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Ammar Sabilarrohman September 12, 2026

For millions of individuals worldwide, the morning ritual is dictated not by fashion or ambition, but by...

Read More Read more about Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Unlocking the Enigma of Metastasis: Weill Cornell and MIT Researchers Identify Key Factor in Colorectal Cancer Spread to Liver

• Medical Research and Clinical Trials

Unlocking the Enigma of Metastasis: Weill Cornell and MIT Researchers Identify Key Factor in Colorectal Cancer Spread to Liver

Ammar Sabilarrohman September 11, 2026

NEW YORK, NY & CAMBRIDGE, MA – June 22, 2024 – In a significant breakthrough offering new...

Read More Read more about Unlocking the Enigma of Metastasis: Weill Cornell and MIT Researchers Identify Key Factor in Colorectal Cancer Spread to Liver

The Invisible Aesthetic: How Nose Shape Defines the Perception of Beauty

• Breast Cancer Surgery and Reconstruction

The Invisible Aesthetic: How Nose Shape Defines the Perception of Beauty

Ammar Sabilarrohman September 10, 2026

In the intricate architecture of the human face, the nose acts as the central pillar. Yet, according...

Read More Read more about The Invisible Aesthetic: How Nose Shape Defines the Perception of Beauty

Bridging the Digital Divide in Orthopaedics: Inside restor3d’s New Patient Engagement Suite

• Treatment Innovations

Bridging the Digital Divide in Orthopaedics: Inside restor3d’s New Patient Engagement Suite

Ammar Sabilarrohman September 10, 2026

The landscape of orthopaedic surgery is undergoing a profound transformation. Moving beyond the traditional focus on hardware—the...

Read More Read more about Bridging the Digital Divide in Orthopaedics: Inside restor3d’s New Patient Engagement Suite

Rewriting the Future of Immunotherapy: Solstice Oncology Takes on the CTLA-4 Challenge

• Treatment Innovations

Rewriting the Future of Immunotherapy: Solstice Oncology Takes on the CTLA-4 Challenge

Ammar Sabilarrohman September 9, 2026

By Gwendolyn Wu | Published September 9, 2026 In the high-stakes arena of cancer drug development, few...

Read More Read more about Rewriting the Future of Immunotherapy: Solstice Oncology Takes on the CTLA-4 Challenge

Cambridge Breakthrough Offers Hope: 100% Survival Rate Achieved in Trial for Aggressive Inherited Breast Cancers

• Medical Research and Clinical Trials

Cambridge Breakthrough Offers Hope: 100% Survival Rate Achieved in Trial for Aggressive Inherited Breast Cancers

Ammar Sabilarrohman September 9, 2026

CAMBRIDGE, UK – In a landmark development that could redefine the treatment landscape for aggressive, inherited breast...

Read More Read more about Cambridge Breakthrough Offers Hope: 100% Survival Rate Achieved in Trial for Aggressive Inherited Breast Cancers

The Invisible Legacy: COVID-19 History Linked to Elevated Blood Clot Risks in Post-Bariatric Surgery Patients

• Breast Cancer Surgery and Reconstruction

The Invisible Legacy: COVID-19 History Linked to Elevated Blood Clot Risks in Post-Bariatric Surgery Patients

Ammar Sabilarrohman September 7, 2026

For millions of individuals who have achieved significant weight loss, body contouring procedures—particularly panniculectomy—represent a final, transformative...

Read More Read more about The Invisible Legacy: COVID-19 History Linked to Elevated Blood Clot Risks in Post-Bariatric Surgery Patients